Gravitate-Health

What Gravitate-Health does

Gravitate-Health is a public-private partnership consortium established in October 2020 under the Innovative Medicines Initiative 2 (IMI2) Joint Undertaking, co-led by the University of Oslo (academic coordinator) and Pfizer (industry lead), with 45 partners across 16 European countries and the United States. Funded by a €19.4M grant from the EU's Horizon 2020 programme, EFPIA, and Datapharm Limited, the project developed G-lens® (Gravitate Lens), a digital tool that personalizes the presentation of electronic Product Information (ePI) by tailoring regulatory medication leaflets to an individual's health data, preferences, and context of use. The initiative is built on the HL7 FHIR ePI standard (the VULCAN profile) and the FOSPS (Federated Open-Source Platform Services) platform, integrated with national digital health systems in Denmark, Portugal, Norway, Sweden, Finland, and the UK rather than delivered as a standalone application.

The consortium serves four primary constituency groups: European citizens and patients who need understandable medication information; healthcare professionals (physicians, pharmacists, nurses) who require up-to-date regulatory content at the point of care; national regulatory authorities (EMA, MEB, AEMPS, NoMA) involved in ePI standard setting and electronic labeling; and pharmaceutical companies (EFPIA members) preparing for mandatory ePI compliance under EU pharmaceutical legislation from 2026. Distribution is achieved through embedded integrations with national health platforms (Danish medication card, Portuguese SN24), Nordic pharmaceutical compendia (Felleskatalogen, Medicin.dk, Fass, Pharmaca), and Datapharm's emc (over 70 million annual visitors), giving G-lens a potential reach of more than 100 million annual pageviews across partner channels.

The project concluded in June 2026 with a Final Conference in Brussels and the launch of the Gravitate Center for Trusted Health Information, a sustainability entity led by the University of Oslo. The consortium is not a commercially operating company; there is no traditional revenue model, pricing structure, or sales motion. Value is generated through standards contribution, ecosystem coordination, and the positioning of partners for the EU's mandatory ePI framework, with the G-lens® trademark and FOSPS open-source platform as the principal intangible assets.

Name

Gravitate-Health

Legal name

Gravitate Health Consortium

Website

https://gravitatehealth.eu

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Gravitate-Health is a 45-partner IMI2-funded public-private consortium developing G-lens®, a digital tool that personalizes electronic Product Information (ePI) for European citizens, healthcare professionals, regulators, and pharmaceutical companies via HL7 FHIR standards and national health system integrations.

Ownership category

akta.pro rank

Product category

Digital Health Information / Healthcare Software

NAICS

Computer Systems Design Services (541512), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Interoperability Standards, Profiles & Implementation (HL7/FHIR/IHE) (HLACABAA)

Keywords

• Electronic product information
• Digital health information
• Personalized medication leaflets
• HL7 FHIR standards
• Patient-centric health data

Headquarters

HQ city

Oslo

HQ country

Norway

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. EU Research Grant Funding: Gravitate-Health is funded through the Innovative Medicines Initiative 2 (IMI2) Joint Undertaking with total budget of €19.4M. Funding comes from EU's Horizon 2020 research program, EFPIA, and Datapharm Limited. Project duration was initially 60 months with an 8-month extension granted.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Gravitate-Health develops the G-lens® (Gravitate Lens), a digital tool that tailors electronic Product Information (ePI) to an individual's personal health data, preferences, and context of use, deployed through the FOSPS open-source platform. The consortium also drives adoption of the global HL7 FHIR ePI standard aligned with EMA requirements and integrates its technology into existing national digital health systems across Europe.

Product overview

Gravitate Health is a public-private partnership project developing an integrated digital health information ecosystem. The core offering consists of the G-lens (Gravitate Lens), a digital tool that provides personalized presentation of electronic Product Information (ePI) by tailoring medication leaflets based on individual health data, preferences, and context. This is built upon FOSPS (Federated Open-Source Platform Services), an open-source technology platform that integrates common services and enables interoperability with national digital health systems. The project also drives adoption of the HL7 FHIR ePI standard and provides multilingual content access, integrating its focusing mechanisms into existing systems such as the Danish medication card and Portuguese SN24 platform.

Differentiator

Problem solved

Functional benefit

Brands

• G-lens® (Gravitate Lens): A digital tool that provides personalized presentation of electronic Product Information (ePI) by tailoring medication leaflets to an individual's specific needs based on their personal health data, preferences, and context of use.
• FOSPS
• Gravitate Centre for Trusted Health Information

Products and services

• G-lens® (Gravitate Lens) A digital tool providing personalized presentation of electronic Product Information (ePI) by tailoring medication leaflets to an individual's specific needs based on personal health data, preferences, and context of use. Focuses (but does not conceal or filter) approved ePI content to highlight essential medication information. Used by citizens/patients via integration with national digital health systems in Europe.
• FOSPS (Federated Open-Source Platform Services) An open-source technology platform developed by the consortium that integrates common services for digital health information delivery and enables integration with national digital health systems across Europe. Used by health IT integrators, technology partners, and clinical implementers.
• HL7 FHIR ePI Standard The HL7 FHIR ePI standard (VULCAN ePI profile) developed in alignment with European Medicines Agency (EMA) requirements and ready for global use. Enables machine-readable, real-time updates, and seamless interoperability with EHR systems. Targeted at standards bodies, regulators, health IT vendors, and pharmaceutical companies.
• Multilingual ePI Content Provides medicine information in a citizen's language of choice, integrated with national digital health systems and Nordic pharmaceutical compendia. Critical for patient safety, understanding, and cross-border mobility within Europe.

Quantifiable outcome

• ePI becoming mandatory regulatory requirement in EU from 2026
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

46 partnerships are on record, tiered core, major and minor.

• University of Oslo (UiO)coreStrategic or Co-development PartnerProject Coordinator leading all project management activities and overall coordination. Academic lead contributing across all work packages with experience in digital health tools for citizen-centered medication management. Led development of use-cases, personas, and oversight of testing scenarios.
• Pfizer LimitedcoreStrategic or Co-development PartnerEFPIA Project Leader responsible for overall scientific and action-related governance. Industry lead providing leadership across workstreams focused on stakeholder engagement, user-focused digital tools, interoperability, standards, regulatory requirements, and project management.
• HL7 EuropecoreTechnology or IntegrationStandards development organization leading interoperability aspects and co-leading WP5. Supports refinement of HL7 FHIR standards and implementation guides for testing and validation of G-lens concept and ePI standard.
• European Medicines Agency (EMA)coreStrategic or Co-development PartnerRegulatory authority collaborating on ePI pilot projects and alignment of FHIR ePI standards with European regulatory requirements. Key stakeholder in EU pharmaceutical legislation developments.
• AstraZeneca ABmajorStrategic or Co-development PartnerEFPIA partner active in WP2 (Engagement), WP6 (Evaluation), and WP7 (Sustainability). Contributing therapeutic area expertise, patient safety knowledge, and experience in drug development.
• Bayer AktiengesellschaftmajorStrategic or Co-development PartnerCo-Lead Industry partner for WP1 (Listening) and Regulatory/Product Information Lead in Steering Committee. Contributing regulatory affairs expertise, patient engagement, labeling, and e-labeling experience.
• Novartis Pharma AGmajorStrategic or Co-development PartnerActive in WP1, WP2, and WP5. Contributing pharmaceutical regulatory and labelling experience, and company expertise in drug development and patient care.
• Roche (F. Hoffmann-La Roche AG)majorStrategic or Co-development PartnerIndustry co-lead for WP7 and Sustainability/Innovation Coordination in Steering Committee. Contributing experience in digital tools for risk minimization and patient support programs.
• Eli Lilly and Company LimitedmajorStrategic or Co-development PartnerActive across WP1-WP7. Contributing regulatory affairs expertise and innovative IT/Digital solutions including web platforms, chatbots, and medical information services.
• UCB Biopharma SRLmajorStrategic or Co-development PartnerCo-lead for WP6 (Evaluation) and active in WP1 and WP5. Contributing pharmaceutical experience in Medical Affairs, Medical Information, Patient Support Programs, and Clinical Development.
• ViatrismajorStrategic or Co-development PartnerActive in WP1 and WP6. Contributing experience in pharmaceuticals, regulatory affairs, IT technology, and market access, including participation in IATF ePI working group.
• Janssen (Johnson & Johnson)majorStrategic or Co-development PartnerEFPIA partner contributing to consortium activities in pharmaceutical development and patient care solutions.
• Grünenthal GmbHmajorStrategic or Co-development PartnerActive in WP1, WP5, WP6, and WP7. Contributing expertise in pain management, patient-centric approaches, and leading IATF ePI Taskforce participation.
• Medicines Evaluation Board (MEB)coreStrategic or Co-development PartnerDutch regulatory authority member of ePI information model team and engagement/capacity building. Contributing data on patient information needs and ePI lifecycle optimization.
• Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)coreStrategic or Co-development PartnerSpanish regulatory agency active in user needs, end-user tools, ePI development, and sustainability analysis. Developed software for national electronic SPC/leaflet and chairs ePI implementation group.
• Norwegian Medical Products Agency (NoMA/DMP)coreStrategic or Co-development PartnerNational competent authority representing Norway in EU scientific committees. Bringing regulatory perspective and long-standing cooperation with Felleskatalogen on electronic product information.
• European Patients' Forum (EPF)coreStrategic or Co-development PartnerUmbrella patient organization co-leading capacity building and multi-stakeholder engagement. Contributing patient perspective, digital health literacy expertise, and ensuring stakeholder alignment.
• Karolinska InstitutetmajorStrategic or Co-development PartnerAcademic partner co-leading WP1, developing information models and semantic work. Contributing design of collaboration tools and co-founding ICHOM.
• University of Copenhagen (CORS)majorStrategic or Co-development PartnerAcademic partner contributing to WP7 on sustainability and risk minimization strategies. Contributing regulatory science expertise and methodologies for benefit-risk decision-making.
• Trinity College DublinmajorStrategic or Co-development PartnerAcademic partner leading KPI finalization, active in WP1, WP4, and WP6. Leading testing scenarios on young people with complex needs and overseeing G-lens evaluation.
• University College Dublin (UCD)majorStrategic or Co-development PartnerAcademic partner disseminating KPIs and leading testing scenarios on young people with complex needs. Ranked top 1% globally with strong health research programs.
• Oslo University HospitalmajorStrategic or Co-development PartnerHealthcare provider active in WP6 as site for Norwegian IBD testing scenarios. Developing and testing digital platform for better health literacy and medication compliance.
• Akershus University HospitalmajorStrategic or Co-development PartnerTeaching hospital participating in testing scenarios (WP1, WP4, WP6), WP5 for interoperability, and WP7 for exploitation. Offering extensive experience in patient interaction and HL7 FHIR representation.
• Serviços Partilhados do Ministério da Saúde (SPMS)coreStrategic or Co-development PartnerPortuguese national health IT authority contributing testing scenario for Type 2 Diabetes patients. Active in WP1, WP4, WP6, WP8 with expertise in ePrescription and national health platforms.
• Servicio Madrileño de Salud (SERMAS)majorStrategic or Co-development PartnerLargest regional healthcare organization in Spain leading testing scenario on poly-medicated patients. Active across WP1, WP2, WP4, WP6, WP8 with expertise in clinical decision support systems.
• Medidata (MDSOL Europe Ltd)majorTechnology or IntegrationClinical trial software provider co-leading WP3 for building G-lens platform. Contributing technical and business perspectives with expertise in e-Clinical systems and EHR integration.
• Trifork Public A/SmajorTechnology or IntegrationTechnology company with 12+ years developing Danish Shared Medication Record. Assessing feasibility of integration with Danish digital ecosystem for G-lens functionality testing.
• Guardtime OÜmajorTechnology or IntegrationCyber security company providing KSI Blockchain technology. Active in WP3 (G-lens platform) and WP5, leading secured data sharing and trusted ledger component development.
• Datawizard SRLmajorTechnology or IntegrationDigital health SME co-leading WP4 on digital solution implementation, UX design, and front-end development. Contributing Pharmawizard experience and system integration expertise.
• Datapharm LimitedcoreTechnology or IntegrationIMI2 Associated Partner operating emc (electronic medicines compendium) with 70M+ annual visitors. Active in WP1, WP5, WP7. Leading experts in electronic prescribing information and XML conversion.
• FelleskatalogencoreTechnology or IntegrationNorwegian pharmaceutical compendium preparing FHIR ePI for Nordic test scenarios. Contributing 20+ years of digital package leaflet experience and working with NoMA and EMA on FHIR ePI standard.
• Medicin.dkcoreTechnology or IntegrationDanish pharmaceutical information provider with 100M+ annual pageviews. Contributing testing scenarios with quality-controlled ePILs in Nordic countries and experience in medicinal information structuring.
• FasscoreTechnology or IntegrationSwedish pharmaceutical compendium with 4M+ monthly visits. Providing cross-border Nordic ePIL cooperation and 50+ years of experience in digital medicinal information.
• Pharmaca Health IntelligencecoreTechnology or IntegrationFinnish pharmaceutical intelligence company preparing FHIR ePI repository. Contributing nearly 50 years of experience in digital pharmaceutical information and national ePrescription database management.
• Universidad Politécnica de Madrid (UPM) - LifeSTechmajorTechnology or IntegrationTechnical university co-leading FOSPS platform development and content transformation. Contributing ICT expertise in pharmacological treatment, personalized medicine, and participation in 150+ R&D projects.
• Norwegian Centre for eHealth Research (NSE)majorStrategic or Co-development PartnerNorway's largest e-health research center active in WP1, WP2, WP4, WP6, WP7. Contributing 25 years of telemedicine/eHealth experience and Research Network for Digital Medicine Management.
• Norsk e-Helse ASmajorTechnology or IntegrationTechnology company building G-lens platform (WP3) and contributing EHR development expertise. Developed DocuLive EPR and implementing HL7 FHIR medication module for patient interaction.
• HIMSS EuropemajorStrategic or Co-development PartnerHealth IT membership organization providing EU policy expertise, legal/regulatory/ethical guidance, and event organization. Contributing via Ethical/Legal Coordination Lead role in Steering Committee.
• The European Institute for Innovation through Health Data (i-HD)coreStrategic or Co-development PartnerNot-for-profit organization leading WP6 on piloting and evaluation. Leading business modeling and sustainability strategy, organizing conferences on health data use.
• The SynergistmajorStrategic or Co-development PartnerSocial venture building partnerships for stakeholder engagement. Active in WP1 and WP2, leading stakeholder elicitation tasks with 9,000+ ecosystem members.
• Global Health ConnectormajorStrategic or Co-development PartnerOrganization facilitating multi-stakeholder connections across 90+ health ecosystems in 78 countries. Dissemination Manager leading WP1, WP2, WP7, WP8 stakeholder engagement.
• empiricamajorStrategic or Co-development PartnerResearch consultancy co-leading WP7 on sustainability and exploitation. Contributing 30 years of EU project experience in digital health policies, interoperability, and socio-economic assessment.
• PredictBymajorStrategic or Co-development PartnerResearch and consulting firm leading cost-effectiveness analysis and HTA tasks. Contributing 15+ years of HTA experience and expertise in regulatory aspects of digital health.
• Beth Israel Deaconess Medical Center (DCI)majorStrategic or Co-development PartnerHarvard-affiliated research division active in WP2, WP4, WP6. Contributing clinical informatics expertise, InfoSAGE and Alicanto systems, and research on patient engagement and decision support.
• Università Cattolica del Sacro Cuore - EngageMinds HUBmajorStrategic or Co-development PartnerResearch center contributing to WP4 and WP6 with evidence-based behavioral change framework. Contributing PHE Model for assessing patient psychological readiness for health management.
• MINDVIEW Business ConsultingminorStrategic or Co-development PartnerConsultancy engaging stakeholders and public/patient end-users. Co-leading public engagement and developing Gravitate Health website and communication tools.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Felleskatalogen: Norwegian pharmaceutical compendium with 20+ years of digital package leaflet experience; core Gravitate-Health partner preparing FHIR ePI for Nordic test scenarios and working with NoMA on the standard.
• Pharmaca Health Intelligence (Finland): Finnish pharmaceutical intelligence company preparing FHIR ePI repository and managing the national ePrescription database; near-50-year history in digital pharmaceutical information comparable to Gravitate-Health's mission.
• Datapharm: Operates emc (electronic medicines compendium) reaching 70M+ annual visitors; Gravitate-Health's core distribution partner and IMI2 associated partner, providing parallel electronic product information delivery to UK healthcare professionals and patients.
• Fass (Swedish Pharma Compendium): Swedish pharmaceutical compendium with 4M+ monthly visits and 50+ years of digital medicinal information experience; partner providing cross-border Nordic ePIL cooperation.
• HL7 Europe: Standards development organization that co-developed the HL7 FHIR ePI profile with Gravitate-Health; HL7 Europe's Secretary General Catherine Chronaki serves as Gravitate-Health's Interoperability Lead.
• Medicin.dk: Danish pharmaceutical information provider with 100M+ annual pageviews; core partner contributing testing scenarios and structured ePILs in Nordic countries — directly comparable in delivering medicine information to citizens.
• i~HD (European Institute for Innovation through Health Data): Not-for-profit leading Gravitate-Health's WP6 on piloting and evaluation, and responsible for the project's business modeling and sustainability strategy; closely aligned mission on trusted health data use.

Emerging players

• openEHR Foundation: Open-specification community for electronic health records; competing standards initiative in the European digital health interoperability space where Gravitate-Health's FHIR ePI profile operates.

Others

• European Medicines Agency (EMA): EU regulatory authority driving the ePI mandate from 2026; Gravitate-Health is a key collaborator shaping the HL7 FHIR ePI standard that EMA is aligning with, making EMA both an ecosystem participant and a regulatory dependency.

Broad incumbents

• Wolters Kluwer Health (Medi-Span / Clinical Solutions): Large incumbent providing clinical drug information (Medi-Span, Lexicomp, UpToDate) to hospitals and EHRs globally; competes for the same pharmaceutical information delivery workflow that Gravitate-Health's G-lens® targets.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/gravitatehealth
• YouTubeyoutube.com/channel/UCRsV-nZ5XT0C1bhLS0T-FqQ
• Facebookfacebook.com/GravitateHealth
• LinkedInlinkedin.com/company/gravitatehealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gravitate-Health